Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Brent NeidigChief Commercial Officer | Usana Health SciencesUSNA | Open-market sale | 06/16 | 06/18 | 5,002 sh | $19.45 | $97,288.9 | −100.0% |
Usana Health SciencesUSNA | Open-market sale | 06/12–06/15 | 06/16 | 2,511 sh2 trades | $20.10avg. | $50,469.39 | −33.4% | |
Paul A. JonesChief People Officer | Usana Health SciencesUSNA | Open-market sale | 06/08 | 06/08 | 5,561 sh | $18.50 | $102,878.5 | −100.0% |
John Turman FlemingDirector | Usana Health SciencesUSNA | Open-market sale | 06/01 | 06/01 | 2,450 sh | $17.93 | $43,928.5 | −36.7% |
Paul A. JonesChief People Officer | Usana Health SciencesUSNA | Open-market sale | 05/28 | 05/29 | 6,813 sh | $18.95 | $129,106.35 | −55.1% |
Usana Health SciencesUSNA | Open-market sale | 05/27 | 05/28 | 5,360 sh | $18.75 | $100,500 | −100.0% | |
Gilbert A. FullerDirector | Usana Health SciencesUSNA | Open-market sale | 05/22 | 05/26 | 1,057 sh | $18.66 | $19,723.62 | −100.0% |
Joshua FoukasChief Legal Officer | Usana Health SciencesUSNA | Open-market sale | 05/07 | 05/08 | 3,791 sh | $19.82 | $75,137.62 | −100.0% |
Gilbert A. FullerDirector | Usana Health SciencesUSNA | Open-market sale | 03/20 | 03/20 | 1,058 sh | $17.00 | $17,986 | −100.0% |
Peter BenedictChief Information Officer | Usana Health SciencesUSNA | Open-market sale | 03/03 | 03/03 | 4,553 sh | $19.38 | $88,237.14 | −100.0% |
Joshua FoukasChief Legal Officer | Usana Health SciencesUSNA | Open-market sale | 02/20 | 02/23 | 4,461 sh | $21.35 | $95,242.35 | −100.0% |
David Mulham MulhamChief Sales Officer | Usana Health SciencesUSNA | Open-market sale | 25/12/10 | 25/12/11 | 873 sh | $21.00 | $18,333 | −9.4% |
Peter BenedictChief Information Officer | Usana Health SciencesUSNA | Open-market sale | 25/12/10 | 25/12/11 | 2,673 sh | $20.95 | $55,999.35 | −100.0% |
Frederic J. WinssingerDirector | Usana Health SciencesUSNA | Open-market sale | 25/11/10 | 25/11/10 | 2,000 sh | $19.21 | $38,420 | −25.0% |
Gilbert A. FullerDirector | Usana Health SciencesUSNA | Open-market sale | 25/11/03 | 25/11/04 | 1,057 sh | $21.48 | $22,704.36 | −100.0% |
John Turman FlemingDirector | Usana Health SciencesUSNA | Open-market sale | 25/10/31 | 25/11/03 | 1,750 sh | $19.79 | $34,632.5 | −27.7% |
Gilbert A. FullerDirector | Usana Health SciencesUSNA | Open-market sale | 25/08/07 | 25/08/08 | 1,058 sh | $29.10 | $30,787.8 | −100.0% |
David Mulham MulhamChief Sales Officer | Usana Health SciencesUSNA | Open-market sale | 25/07/30 | 25/07/31 | 3,515 sh | $30.26 | $106,363.9 | −27.5% |
John Turman FlemingDirector | Usana Health SciencesUSNA | Open-market sale | 25/06/09 | 25/06/10 | 500 sh | $29.66 | $14,830 | −10.6% |
Walter NootCOO | Usana Health SciencesUSNA | Open-market sale | 25/05/27 | 25/05/29 | 6,291 sh | $30.29 | $190,554.39 | −100.0% |